RICCHETTI INCORPORATED for AMGEN INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 16, 2025 | $60,000 | Replaced |
| 4th Quarter - Termination | Jan 21, 2025 | $60,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to drug pricing and access, Medicare and Medicaid reimbursement; Issues relating to the Medicaid drug rebate program proposed rule
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFF RICCHETTI | — |
Pharmacy PHA
Issues related to pharmaceutical industry, generally; Drug pricing and access, and Medicare and Medicaid reimbursement
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFF RICCHETTI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.